Novo Nordisk’s GLP-1 agonist Ozempic has shown efficacy in yet another indication, achieving a 24% reduction in kidney disease-related events in people with type 2 diabetes and chronic kidney disease ...
In a scathing criticism of US President Donald Trump's latest tariff threat, French President Emmanuel Macron said Europe would not be intimidated. The United States plans to reduce the number of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback